TY  - JOUR
A1  - Schwarz, Frank
A1  - Alcoforado, Gil
A1  - Guerrero, Adrian
A1  - Jönsson, Daniel
A1  - Klinge, Björn
A1  - Lang, Niklaus P.
A1  - Mattheos, Nikos
A1  - Mertens, Brenda Nilufar
A1  - Pitta, João
A1  - Ramanauskaite, Ausra
A1  - Sayardoust, Shariel
A1  - Sanz-Martin, Ignacio
A1  - Stavropoulos, Andreas
A1  - Heitz-Mayfield, Lisa J. A.
T1  - Peri-implantitis: summary and consensus statements of  group 3. The 6th EAO Consensus Conference 2021
T2  - Clinical oral implants research
N2  - Objective: To evaluate the influence of implant and prosthetic components on peri-implant tissue health. A further aim was to evaluate peri-implant soft-tissue changes following surgical peri-implantitis treatment. Materials and methods: Group discussions based on two systematic reviews (SR) and one critical review (CR) addressed (i) the influence of implant material and surface characteristics on the incidence and progression of peri-implantitis, (ii) implant and restorative design elements and the associated risk for peri-implant diseases, and (iii) peri-implant soft-tissue level changes and patient-reported outcomes following peri-implantitis treatment. Consensus statements, clinical recommendations, and implications for future research were discussed within the group and approved during plenary sessions. Results: Data from preclinical in vivo studies demonstrated significantly greater radiographic bone loss and increased area of inflammatory infiltrate at modified compared to non-modified surface implants. Limited clinical data did not show differences between modified and non-modified implant surfaces in incidence or progression of peri-implantitis (SR). There is some evidence that restricted accessibility for oral hygiene and an emergence angle of >30 combined with a convex emergence profile of the abutment/prosthesis are associated with an increased risk for peri-implantitis (CR). Reconstructive therapy for peri-implantitis resulted in significantly less soft-tissue recession, when compared with access flap. Implantoplasty or the adjunctive use of a barrier membrane had no influence on the extent of peri-implant mucosal recession following peri-implantitis treatment (SR).
KW  - consensus
KW  - peri-implantitis
KW  - risk factors
Y1  - 2021
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63436
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-634363
SN  - 1600-0501
VL  - 32
IS  - S21
SP  - 245
EP  - 253
PB  - Wiley-Blackwell
CY  - Oxford
ER  -